Get the full picture
Sign in to uncover key details.
imaGeneBio
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
12526 High Bluff Dr Ste 345, San Diego, ...Website
www.imagenebio.comRevenue
-Stock Symbol
IMAIndustry
About imaGeneBio
ImageneBio, Inc. is a global clinical-stage biotechnology company headquartered in San Diego, California, focused on developing novel therapeutics for patients with immunological, autoimmune, and inflammatory diseases. The company is dedicated to advancing differentiated treatment approaches that target key immune pathways involved in T cell activation and inflammatory disease progression. ImageneBio's pipeline is designed to address conditions with significant unmet medical need, including atopic dermatitis and alopecia areata. ImageneBio trades on the NASDAQ under the ticker symbol IMA.Explore more
imaGeneBio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to imaGeneBio
Compare insights from companies similar to imaGeneBio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
imaGeneBio Tech Stack
A closer look at the technologies used by imaGeneBio
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding imaGeneBio
Sign Up For FreeTo access detailed company insights
ImageneBio, Inc. is a global clinical-stage biotechnology company headquartered in San Diego, California, focused on developing novel therapeutics for patients with immunological, autoimmune, and inflammatory diseases. The company is dedicated to advancing differentiated treatment approaches that target key immune pathways involved in T cell activa... Read More
